Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02533340
-
Active Ingredients :Lisdexamfetamine Dimesylate
-
Innovator Name:Vyvanse®
-
Category:Central Nervous System Stimulant
-
Dosage form:Chewable Tablets
-
Strength:10 mg
-
Route of Administration:Oral
- Package size:
100 Bottle - UPC Code:
063691102385 -
Description :TARO-LISDEXAMFETAMINE CHEWABLE TABLETS 10 mg: white to off-white, round shaped tablet debossed with ‘10’ on one side and ‘S83’ on the other, bottles of 100.
-
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose, strawberry flavour, strawberry cream flavor, and sucralose.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02533359
-
Active Ingredients :Lisdexamfetamine Dimesylate
-
Innovator Name:Vyvanse®
-
Category:Central Nervous System Stimulant
-
Dosage form:Chewable Tablets
-
Strength:20 mg
-
Route of Administration:Oral
- Package size:
100 Bottle - UPC Code:
063691102392 -
Description :TARO-LISDEXAMFETAMINE CHEWABLE TABLETS 20 mg: white to off-white, hexagonal shaped tablet debossed with ‘20’ on one side and ‘S84’ on the other, bottles of 100.
-
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose, strawberry flavour, strawberry cream flavor, and sucralose.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02533367
-
Active Ingredients :Lisdexamfetamine Dimesylate
-
Innovator Name:Vyvanse®
-
Category:Central Nervous System Stimulant
-
Dosage form:Chewable Tablets
-
Strength:30 mg
-
Route of Administration:Oral
- Package size:
100 Bottle - UPC Code:
063691102408 -
Description :TARO-LISDEXAMFETAMINE CHEWABLE TABLETS 30 mg: white to off-white, arc triangular shaped tablet debossed with ‘30’ on one side and ‘S85’ on the other, bottles of 100.
-
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose, strawberry flavour, strawberry cream flavor, and sucralose.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02533375
-
Active Ingredients :Lisdexamfetamine Dimesylate
-
Innovator Name:Vyvanse®
-
Category:Central Nervous System Stimulant
-
Dosage form:Chewable Tablets
-
Strength:40 mg
-
Route of Administration:Oral
- Package size:
100 Bottle - UPC Code:
063691102415 -
Description :TARO-LISDEXAMFETAMINE CHEWABLE TABLETS 40 mg: white to off-white, capsule shaped tablet debossed with ‘40’ on one side and ‘S86’ on the other, bottles of 100.
-
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose, strawberry flavour, strawberry cream flavor, and sucralose.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02533383
-
Active Ingredients :Lisdexamfetamine Dimesylate
-
Innovator Name:Vyvanse®
-
Category:Central Nervous System Stimulant
-
Dosage form:Chewable Tablets
-
Strength:50 mg
-
Route of Administration:Oral
- Package size:
100 Bottle - UPC Code:
063691102422 -
Description :TARO-LISDEXAMFETAMINE CHEWABLE TABLETS 50 mg: white to off-white, arc square shaped tablet debossed with ‘50’ on one side and ‘S87’ on the other, bottles of 100.
-
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose, strawberry flavour, strawberry cream flavor, and sucralose.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02533391
-
Active Ingredients :Lisdexamfetamine Dimesylate
-
Innovator Name:Vyvanse®
-
Category:Central Nervous System Stimulant
-
Dosage form:Chewable Tablets
-
Strength:60 mg
-
Route of Administration:Oral
- Package size:
100 Bottle - UPC Code:
063691102439 -
Description :TARO-LISDEXAMFETAMINE CHEWABLE TABLETS 60 mg: white to off-white, arc diamond shaped tablet debossed with ‘60’ on one side and ‘S88’ on the other, bottles of 100.
-
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose, strawberry flavour, strawberry cream flavor, and sucralose.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here